Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Revenue (2016 - 2025)

Historic Revenue for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Dexcom's Revenue rose 1312.08% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.7 billion, marking a year-over-year increase of 1559.63%. This contributed to the annual value of $4.7 billion for FY2025, which is 1559.63% up from last year.
  • As of Q4 2025, Dexcom's Revenue stood at $1.3 billion, which was up 1312.08% from $1.2 billion recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Revenue peaked at $1.3 billion during Q4 2025, and registered a low of $505.0 million during Q1 2021.
  • For the 5-year period, Dexcom's Revenue averaged around $883.8 million, with its median value being $896.2 million (2023).
  • Per our database at Business Quant, Dexcom's Revenue skyrocketed by 3171.76% in 2021 and then soared by 196.92% in 2024.
  • Dexcom's Revenue (Quarter) stood at $698.2 million in 2021, then rose by 16.76% to $815.2 million in 2022, then increased by 26.9% to $1.0 billion in 2023, then rose by 7.64% to $1.1 billion in 2024, then rose by 13.12% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $1.2 billion for Q3 2025, and $1.2 billion during Q2 2025.